PEAK6 Investments’s Maravai LifeSciences MRVI Stock Holding History

PEAK6 Investments’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-93	Closed	-$1.16K	–	4386
2023 Q2	$1.16K	Sell	93 -2,807	-97%	-$37.9K	﹤0.01%	3769
2023 Q1	$40.6K	Buy	+2,900	New	+$41.7K	﹤0.01%	3786
2022 Q4	–	Sell	-8,465	Closed	-$216K	–	4920
2022 Q3	$216K	Buy	8,465 +8,372	+9,002%	+$210K	﹤0.01%	3597
2022 Q2	$1.16K	Buy	+93	New	+$2.95K	﹤0.01%	6008

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

PEAK6 Investments's MRVI Position: Q3 2023 in Review

PEAK6 Investments sold out of Maravai LifeSciences (MRVI) in Q3 2023, closing a stake of 93 shares — an estimated $1.16K sold.

PEAK6 Investments first reported a position in MRVI in Q2 2022 and held it in 4 quarters. The position peaked at $216K in Q3 2022. 204 funds tracked by Wall St. Rank hold MRVI as of Q3 2023.

PEAK6 Investments reported no remaining Maravai LifeSciences position as of Q3 2023 after selling out during the quarter.
PEAK6 Investments sold 93 Maravai LifeSciences shares in Q3 2023, an estimated $1.16K.
PEAK6 Investments first reported a position in Maravai LifeSciences in Q2 2022 and held it in 4 quarters.
PEAK6 Investments's Maravai LifeSciences position peaked at $216K in Q3 2022.
204 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.